Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 3Neurotoxicity Syndromes 2Brain Neoplasms 2Teratoma, Ovarian 1Small Cell Lung Carcinoma 1Sexuality 1Seizures 1Rectal Neoplasms 1Prostatic Neoplasms 1Pain 1Ovarian Neoplasms 1Oligodendroglioma 1Neoplasms 1Medulloblastoma 1Lung Neoplasms 1Glioma 1Glioblastoma 1Fatigue 1Fallopian Tube Neoplasms 1Dysgerminoma 1Colorectal Neoplasms 1Colonic Neoplasms 1Cognition Disorders 1Central Nervous System Carcinoma 1Carcinoma, Non-Small-Cell Lung 1Brenner Tumor 1Breast Neoplasms, Male 1Basal Cell Nevus Syndrome 1Astrocytoma 1

Interventions

Taxes 1Polymerase Chain Reaction 1Mental Status and Dementia Tests 1Gene Expression Profiling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Teratoma, Ovarian × Mental Status and Dementia Tests × Clear all
NCT01080521 2018-04-12

Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy

GOG Foundation

Completed
247 enrolled
Gynecologic

Teratoma, Ovarian, Brenner Tumor, Dysgerminoma, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡